LOC401588 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.730200E-01
Normal-vs-Stage2
4.686800E-01
Normal-vs-Stage3
1.366640E-01
Normal-vs-Stage4
8.277000E-01
Stage1-vs-Stage2
1.638560E-01
Stage1-vs-Stage3
1.081560E-01
Stage1-vs-Stage4
2.689600E-01
Stage2-vs-Stage3
2.011600E-01
Stage2-vs-Stage4
7.159600E-01
Stage3-vs-Stage4
3.454800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.484400E-01
Normal-vs-AfricanAmerican
5.782200E-01
Normal-vs-Asian
4.736800E-01
Caucasian-vs-AfricanAmerican
2.972800E-01
Caucasian-vs-Asian
1.292570E-01
AfricanAmerican-vs-Asian
9.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.565600E-01
Normal-vs-Female
8.388400E-01
Male-vs-Female
1.043610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.442200E-01
Normal-vs-Age(41-60Yrs)
8.637200E-01
Normal-vs-Age(61-80Yrs)
9.522200E-01
Normal-vs-Age(81-100Yrs)
2.285000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.217400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.686600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.982200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.962400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.320100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.904300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.949600E-01
Normal-vs-Daily Drinker
9.888800E-01
Normal-vs-Weekly Drinker
5.486600E-01
Normal-vs-Occasional Drinker
7.375800E-01
Normal-vs-Social Drinker
6.272000E-01
Non Drinker-vs-Daily Drinker
2.164000E-01
Non Drinker-vs-Weekly Drinker
5.040200E-01
Non Drinker-vs-Occasional Drinker
2.145600E-01
Non Drinker-vs-Social Drinker
1.423440E-01
Daily Drinker-vs-Weekly Drinker
4.407600E-01
Daily Drinker-vs-Occasional Drinker
4.361000E-01
Daily Drinker-vs-Social Drinker
2.996000E-01
Weekly Drinker-vs-Occasional Drinker
2.753400E-01
Weekly Drinker-vs-Social Drinker
1.847750E-01
Occasional Drinker-vs-Social Drinker
8.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.068600E-01
Normal-vs-Grade 2
4.800200E-01
Normal-vs-Grade 3
5.169400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.115600E-02
Grade 1-vs-Grade 3
6.494400E-02
Grade 1-vs-Grade 4
5.068600E-01
Grade 2-vs-Grade 3
7.120400E-01
Grade 2-vs-Grade 4
4.800200E-01
Grade 3-vs-Grade 4
5.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.208600E-01
Normal-vs-NonDiabetic
8.960200E-01
Diabetic-vs-NonDiabetic
4.912200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.933400E-01
Normal-vs-NoPancreatitis
9.646200E-01
Pancreatitis-vs-NoPancreatitis
6.817200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.258200E-01
Normal-vs-N1
4.217000E-01
N0-vs-N1
3.437900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.856800E-01
Normal-vs-TP53-NonMutant
6.178000E-01
TP53-Mutant-vs-TP53-NonMutant
3.420300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
